These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 2275209)

  • 1. Hepatic induction potency of hypolipidaemic drugs in the rat following long-term administration: influence of different dosing regimens.
    Makowska JM; Bonner FW; Gibson GG
    Xenobiotica; 1990 Nov; 20(11):1121-8. PubMed ID: 2275209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative pharmacokinetics and gastric toxicity of bezafibrate and ciprofibrate in the rat.
    Eason CT; Powles P; Henry G; Spencer AJ; Pattison A; Bonner FW
    Xenobiotica; 1989 Aug; 19(8):913-25. PubMed ID: 2815833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
    Amacher DE; Beck R; Schomaker SJ; Kenny CV
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference between guinea pig and rat in the liver peroxisomal response to equivalent plasmatic level of ciprofibrate.
    Pacot C; Petit M; Rollin M; Behechti N; Moisant M; Deslex P; Althoff J; Lhuguenot JC; Latruffe N
    Arch Biochem Biophys; 1996 Mar; 327(1):181-8. PubMed ID: 8615689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat.
    Graham MJ; Winham MA; Old SL; Gray TJ
    Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat.
    Nemali MR; Usuda N; Reddy MK; Oyasu K; Hashimoto T; Osumi T; Rao MS; Reddy JK
    Cancer Res; 1988 Sep; 48(18):5316-24. PubMed ID: 2900680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes.
    Perrone CE; Shao L; Williams GM
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):277-86. PubMed ID: 9653058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hypolipidaemic drugs on hepatomegaly and micro-bodies in the rat. A new approach to the nature of hepatic peroxisomal proliferation.
    Sim AK; Spencer A; Metz G; Rushton B
    Arzneimittelforschung; 1981; 31(7):1119-26. PubMed ID: 7196761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comitogenicity of eicosanoids and the peroxisome proliferator ciprofibrate in cultured rat hepatocytes.
    Hong JT; Glauert HP
    J Cell Physiol; 1996 Nov; 169(2):309-19. PubMed ID: 8908198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of peroxisomal beta-oxidation by nonsteroidal anti-inflammatory drugs.
    Foxworthy PS; Perry DN; Eacho PI
    Toxicol Appl Pharmacol; 1993 Feb; 118(2):271-4. PubMed ID: 8442005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of hypolipidaemic agents on peroxisomal beta-oxidation and mixed-function oxidase activities in primary cultures of rat hepatocytes. Relationship between induction of palmitoyl-CoA oxidation and lauric acid hydroxylation.
    Lake BG; Gray TJ; Pels Rijcken WR; Beamand JA; Gangolli SD
    Xenobiotica; 1984 Mar; 14(3):269-76. PubMed ID: 6711016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hypolipidemic drugs gemfibrozil, ciprofibrate, and clofibric acid on peroxisomal beta-oxidation in primary cultures of rainbow trout hepatocytes.
    Donohue M; Baldwin LA; Leonard DA; Kostecki PT; Calabrese EJ
    Ecotoxicol Environ Saf; 1993 Oct; 26(2):127-32. PubMed ID: 7504609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator.
    Rao MS; Lalwani ND; Watanabe TK; Reddy JK
    Cancer Res; 1984 Mar; 44(3):1072-6. PubMed ID: 6692393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferation and beta-oxidation in Fao and MH1C1 rat hepatoma cells, HepG2 human hepatoblastoma cells and cultured human hepatocytes: effect of ciprofibrate.
    Duclos S; Bride J; Ramirez LC; Bournot P
    Eur J Cell Biol; 1997 Apr; 72(4):314-23. PubMed ID: 9127731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of two peroxisome proliferators (ciprofibrate and fenofibrate) on peroxisomal membrane proteins and dihydroxyacetone-phosphate acyl-transferase activity in rat liver.
    Causeret C; Bentejac M; Clemencet MC; Bugaut M
    Cell Mol Biol (Noisy-le-grand); 1993 Feb; 39(1):65-80. PubMed ID: 8467241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of ciprofibrate on renal and hepatic cytochrome P450 2E1 expression.
    Zangar RC; Woodcroft KJ; Novak RF
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):110-6. PubMed ID: 8917682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human HepG2 and rat Fao hepatic-derived cell lines show different responses to ciprofibrate, a peroxisome proliferator: analysis by flow cytometry.
    Passilly P; Jannin B; Hassell SJ; Latruffe N
    Exp Cell Res; 1996 Mar; 223(2):436-42. PubMed ID: 8601421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of peroxisome proliferation in marmoset liver following treatment with ciprofibrate for 3 years.
    Graham MJ; Wilson SA; Winham MA; Spencer AJ; Rees JA; Old SL; Bonner FW
    Fundam Appl Toxicol; 1994 Jan; 22(1):58-64. PubMed ID: 8125214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relative hypolipidaemic activity and hepatic effects of ciprofibrate enantiomers in the rat.
    Graham MJ; Winham MA; Harpur ES; Bonner FW; Gray TJ
    Biochem Pharmacol; 1994 Dec; 48(12):2163-71. PubMed ID: 7811297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.